Financial statements Kalmedica
Balance sheet data of KALMEDICA
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 17 402 157,69 | 18 310 878,31 | 12 982 705,74 | 14 459 961,72 | 14 390 077,03 |
| A. Fixed assets | 15 747 922,23 | 1 522 827,06 | 11 079 140,08 | 10 536 053,05 | 10 699 277,13 |
| B. Current assets | 1 654 235,46 | 16 788 051,25 | 1 903 565,66 | 3 923 908,67 | 3 690 799,90 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 17 402 157,69 | 18 310 878,31 | 12 982 705,74 | 14 459 961,72 | 14 390 077,03 |
| A. Equity | 10 167 981,47 | 9 775 071,61 | 5 434 740,83 | 5 525 724,58 | 5 750 762,86 |
| B. Liabilities and provisions for liabilities | 7 234 176,22 | 8 535 806,70 | 7 547 964,91 | 8 934 237,14 | 8 639 314,17 |
| I. Long-term liabilities | 0,00 | - | - | - | - |
| II. Short-term liabilities | 6 646 352,48 | 7 947 982,96 | 6 960 141,17 | 8 346 413,40 | 8 051 490,43 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.